These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Human monkeypox virus: Epidemiologic review and research progress in diagnosis and treatment. Sun Y; Nie W; Tian D; Ye Q J Clin Virol; 2024 Apr; 171():105662. PubMed ID: 38432097 [TBL] [Abstract][Full Text] [Related]
3. Treatment efficacy of cidofovir and brincidofovir against clade II Monkeypox virus isolates. Prévost J; Sloan A; Deschambault Y; Tailor N; Tierney K; Azaransky K; Kammanadiminti S; Barker D; Kodihalli S; Safronetz D Antiviral Res; 2024 Nov; 231():105995. PubMed ID: 39243894 [TBL] [Abstract][Full Text] [Related]
5. Monkeypox: Past, Present, and Future. Khan G; Perveen N Adv Exp Med Biol; 2024; 1451():1-20. PubMed ID: 38801568 [TBL] [Abstract][Full Text] [Related]
6. Treatment and Vaccination for Smallpox and Monkeypox. Saalbach KP Adv Exp Med Biol; 2024; 1451():301-316. PubMed ID: 38801586 [TBL] [Abstract][Full Text] [Related]
7. [Mpox-diagnosis, treatment, immunization, and prognosis]. Buerke M; Böttger P; Lemm H Med Klin Intensivmed Notfmed; 2024 Nov; ():. PubMed ID: 39503781 [TBL] [Abstract][Full Text] [Related]
8. Monkeypox: A clinical update for paediatricians. Huang YA; Howard-Jones AR; Durrani S; Wang Z; Williams PC J Paediatr Child Health; 2022 Sep; 58(9):1532-1538. PubMed ID: 35979896 [TBL] [Abstract][Full Text] [Related]
9. Ocular manifestations of Monkeypox virus (MPXV) infection with viral persistence in ocular samples: A case series. Finamor LPS; Mendes-Correa MC; Rinkevicius M; Macedo G; Sabino EC; Villas-Boas LS; de Paula AV; de Araujo-Heliodoro RH; da Costa AC; Witkin SS; Santos KLC; Palmeira C; Andrade G; Lucena M; de Freitas Santoro D; da Silva LMP; Muccioli C Int J Infect Dis; 2024 Sep; 146():107071. PubMed ID: 38710273 [TBL] [Abstract][Full Text] [Related]
10. Smallpox vaccination and adverse reactions. Guidance for clinicians. Cono J; Casey CG; Bell DM; MMWR Recomm Rep; 2003 Feb; 52(RR-4):1-28. PubMed ID: 12617510 [TBL] [Abstract][Full Text] [Related]
11. Therapeutics for treating mpox in humans. Fox T; Gould S; Princy N; Rowland T; Lutje V; Kuehn R Cochrane Database Syst Rev; 2023 Mar; 3(3):CD015769. PubMed ID: 36916727 [TBL] [Abstract][Full Text] [Related]
12. Mpox (Monkeypox) Virus and Its Co-Infection with HIV, Sexually Transmitted Infections, or Bacterial Superinfections: Double Whammy or a New Prime Culprit? Liu BM; Rakhmanina NY; Yang Z; Bukrinsky MI Viruses; 2024 May; 16(5):. PubMed ID: 38793665 [TBL] [Abstract][Full Text] [Related]
13. Notes from the Field: Mpox Cluster Caused by Tecovirimat-Resistant Monkeypox Virus - Five States, October 2023-February 2024. Gigante CM; Takakuwa J; McGrath D; Kling C; Smith TG; Peng M; Wilkins K; Garrigues JM; Holly T; Barbian H; Kittner A; Haydel D; Ortega E; Richardson G; Hand J; Hacker JK; Espinosa A; Haw M; Kath C; Bielby M; Short K; Johnson K; De La Cruz N; Davidson W; Hughes C; Green NM; Baird N; Rao AK; Hutson CL MMWR Morb Mortal Wkly Rep; 2024 Oct; 73(40):903-905. PubMed ID: 39388389 [TBL] [Abstract][Full Text] [Related]
15. Interim Clinical Treatment Considerations for Severe Manifestations of Mpox - United States, February 2023. Rao AK; Schrodt CA; Minhaj FS; Waltenburg MA; Cash-Goldwasser S; Yu Y; Petersen BW; Hutson C; Damon IK MMWR Morb Mortal Wkly Rep; 2023 Mar; 72(9):232-243. PubMed ID: 36862595 [TBL] [Abstract][Full Text] [Related]
16. Review of virological methods for laboratory diagnosis and characterization of monkeypox virus (MPXV): lessons learned from the 2022 Mpox outbreak. Resman Rus K; Zakotnik S; Sagadin M; Kolenc M; Skubic L; Knap N; Korva M; Poljak M; Avšič-Županc T Acta Dermatovenerol Alp Pannonica Adriat; 2024 Mar; 33(1):23-35. PubMed ID: 38179904 [TBL] [Abstract][Full Text] [Related]
17. Re-Emerging Trend of Mpox Infection: The Indonesia's Experience and Review. Nelwan EJ; Tanadi C; Pajala FB; Stella MM; Tandarto K; Supranoto YTN; Kalaij AGI; Adiwinata R; Nainggolan L; Lie KC; Masyeni S; Sinto R Acta Med Indones; 2024 Jul; 56(3):419-431. PubMed ID: 39463113 [TBL] [Abstract][Full Text] [Related]
18. Epidemiology of the 2022 Mpox Outbreak in the US Veterans Health Administration. Lucero-Obusan C; Oda G; Schirmer P; Edson C; Trevino C; Elbeik T; Holodniy M J Infect Dis; 2024 Mar; 229(Supplement_2):S172-S180. PubMed ID: 38134309 [TBL] [Abstract][Full Text] [Related]
19. Mpox in people with past infection or a complete vaccination course: a global case series. Hazra A; Zucker J; Bell E; Flores J; Gordon L; Mitjà O; Suñer C; Lemaignen A; Jamard S; Nozza S; Nori AV; Pérez-Barragán E; Rodríguez-Aldama JC; Blanco JL; Delaugerre C; Turner D; Fuertes I; Leiro V; Walmsley SL; Orkin CM; Lancet Infect Dis; 2024 Jan; 24(1):57-64. PubMed ID: 37678309 [TBL] [Abstract][Full Text] [Related]
20. Differential diagnosis of exanthematous viruses during the 2022 Mpox outbreak in Minas Gerais, Brazil. Adelino TÉR; Santos SC; Lima MT; da Costa AVB; Guimarães NR; Tomé LMR; Silva MVF; Pereira AM; Luiz KCM; Lamounier LO; Gomes Júnior AC; Ribeiro AA; Alvarez P; Arruda MB; Kroon EG; Guerra-Duarte C; Iani FCdM J Clin Microbiol; 2024 Jun; 62(6):e0010324. PubMed ID: 38785446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]